InvestorsHub Logo
Followers 12
Posts 1064
Boards Moderated 1
Alias Born 08/28/2020

Re: Bearslayer post# 22589

Friday, 05/31/2024 7:44:59 PM

Friday, May 31, 2024 7:44:59 PM

Post# of 22690
Who knows at this point. They could also use the Shell for one pathway (subsidiary) of Vyome Therapeutics, Inc. I.e.. Vyome Therapeutics Limited. This will allow them to raise capital for a specific drug for clinical trials without going full public with Vyome therapeutics, Inc. Just a theory.